Clinical Trial Update: OCT Evaluation 3 Months After Sirolimus Eluting Stent Implantation [Phase 4]

View source ↗

Summary

Clinical trial update reporting OCT evaluation 3 months after sirolimus-eluting stent implantation in coronary artery disease patients (Phase 4, completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Sirolimus-eluting stent (sirolimus-eluting stent)

Snippet

Sponsor: Scitech Produtos Medicos SA | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED